FDA inspection
Gland Pharma Limited: FDA inspection ending May 16, 2019
FDA inspection 1090548 · Voluntary Action Indicated (VAI) · Hyderabad
Key facts
| Inspection ID | 1090548 |
|---|---|
| Firm | Gland Pharma Limited |
| FEI number | 3002647489 |
| Address | Survey 143-148, 150-151 Gandimaisamma, Cross Road, D P Pally, Quthubullapur |
| City | Hyderabad |
| Country | India |
| Fiscal year | 2019 |
| Inspection end date | May 16, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data